Key facts
- This page summarizes Marlan D. Walker's Form 4 filing for TherapeuticsMD, Inc. (TXMD).
- 8 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 20 Feb 2025, 21:07.
Marlan D. Walker - 18 Feb 2025 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)
- Reporting relationship
- Chief Executive Officer
- Issuer ticker
- TXMD
- Reported as of
- 18 Feb 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Feb 2025, 21:07:16 UTC
- Prior SEC filing
- 07 Dec 2023
- Next SEC filing
- 10 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Marlan D. Walker
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Marlan D. Walker filed Form 4 for TherapeuticsMD, Inc. (TXMD) on 20 Feb 2025.
Change
- Previous filing in this sequence was filed on 07 Dec 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TXMD
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +3,467
- Change %
- +5.5%
- Price
- $0.000000
- Shares after
- 66,032
- Date
- 18 Feb 2025
- Ownership
- Direct
TXMD
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +2,311
- Change %
- +3.5%
- Price
- $0.000000
- Shares after
- 68,343
- Date
- 18 Feb 2025
- Ownership
- Direct
TXMD
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +770
- Change %
- +1.1%
- Price
- $0.000000
- Shares after
- 69,113
- Date
- 18 Feb 2025
- Ownership
- Direct
TXMD
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,733
- Change %
- +2.5%
- Price
- $0.000000
- Shares after
- 70,846
- Date
- 18 Feb 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TXMD
transaction
Derivative
Performance Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -3,467
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 18 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,467
- Exercise price
- $0.000000
- Footnotes
- F1
TXMD
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -2,311
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 18 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,311
- Exercise price
- $0.000000
- Footnotes
- F2
TXMD
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -770
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 18 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 770
- Exercise price
- $0.000000
- Footnotes
- F3
TXMD
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,733
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 1,733
- Date
- 18 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,733
- Exercise price
- $0.000000
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 3,467 shares of common stock of the issuer in settlement of PSUs.
Footnote F2
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 2,311 shares of common stock of the issuer in settlement of RSUs, which vested on July 1, 2024.
Footnote F3
Each RSU represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 770 shares of common stock of the issuer in settlement of RSUs, which vested on September 29, 2024.
Footnote F4
Each RSU represents a contingent right to receive one share of common stock of the issuer. The RSUs vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025. On February 18, 2025, the reporting person received 1,733 shares of common stock of the issuer in settlement of RSUs, which vested on March 23, 2024.